T helper cell type 2 cytokine pathway (Th2 cytokine pathway)

The **T helper cell type 2 cytokine pathway** refers to the network of signals initiated by T helper type 2 cells—a subset of CD4+ lymphocytes—that orchestrate humoral immunity against extracellular pathogens like helminths and contribute significantly to allergic inflammation. This process involves secretion of key **cytokines** including interleukin‑4 (**IL‑4**), **IL‑5**, **IL‑9**, **IL‑13**, among others. These mediators promote B-cell class switching for IgE production, activate eosinophils/basophils/mast cells at sites of infection/allergen exposure, induce mucus production in airways/gut epithelium, stimulate tissue remodeling/fibrosis during chronic inflammation or injury repair processes—and counterbalance pro-inflammatory effects from other T-helper subsets like Th1 cells. Dysregulation leads directly to pathologies such as asthma and other allergic disorders; thus individual elements within this cascade are important drug targets for immunomodulatory therapies[1][3][4].

Other names

Th2 cell signalingType 2 helper T cell cytokine responseTh2 immune responseType 2 immunity

For drugs targeting this axis: Inhibition of interleukin binding to its receptor blocks downstream Th2-mediated inflammatory responses. Reduction in eosinophil activation by blocking IL‑5 or its receptor.